Clinical Trial

NIOSH R21 WTC Asthma

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Aim 2: Conduct a pilot RCT of SaMBA-WTC to determine feasibility and preliminary impact in preparation for a fully powered trial. (7M-24M) The investigators will conduct a pilot RCT (n=58) of the SaMBA-WTC model vs. an attention control. Data will be collected on the primary outcomes (asthma control \[asthma control test, ACT\], medication use, inhaler technique) as well as on other secondary outcomes including measures of physical function, self-management behaviors, feasibility and fidelity at baseline, at intervention completion at 3 months, and for sustainability at 6 months. This project will prepare the team for all aspects of a subsequent larger efficacy trial of SaMBA-WTC.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-27.
Status change: Recruiting → Active, Not Recruiting 2026-03-23
Trial Details
NCT Number NCT07222501
Lead Sponsor Icahn School of Medicine at Mount Sinai
Conditions Asthma
Enrollment 56 participants
Start Date 2025-03-03
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-27